Non–Anti-TNF Agents Safe as 1st-Line Rx Before Anti-TNFs

Treatment with vedolizumab or ustekinumab in CD, or vedolizumab in UC, followed by an anti–TNF was found to ...

JANUARY 3, 2025

Pancreatic Duct Brushing Safe, Moderately Effective in Cancer Detection

Pancreatic duct brush cytology and FISH during ERCP were shown to be safe and have moderate accuracy for diagnosing ...

DECEMBER 9, 2024

U.S. Post-ERCP Pancreatitis Rates Higher Than Expected

Rates of post–ERCP pancreatitis may be higher than previously reported, according to the results of a study ...

DECEMBER 9, 2024

Treating Gastric Varices, Portal Pressure Gradient Measurements and Pancreatic Mass Tissue Acquisition

In this month’s column, I picked three recent studies from the endoscopic ultrasound literature published ...

NOVEMBER 14, 2024

Expert Picks From EASL 2024

Ashwani K. Singal, MD, MS, highlights four abstracts from EASL Congress 2024.

OCTOBER 30, 2024

AI Shows Potential to Improve Right Colon ADR Among Trainees

The use of AI-assisted colonoscopy can increase ADRs in the right colon among early trainees, according to new ...

OCTOBER 29, 2024

Guselkumab Shows Maintenance Efficacy in Initial Induction Nonresponders

New data has found guselkumab can be successful as a maintenance therapy even in those who initially did not ...

OCTOBER 27, 2024

Moving Toward Long-Term Motility Assessment

Noninvasive, multiple-day, ambulatory recording of GI myoelectrical activity may translate to more individualized ...

OCTOBER 27, 2024

Statin Use Not Linked to Decreased Liver Fibrosis in Population-Based Study

Statin use may not be associated with less progression of liver fibrosis in the general population, according to ...

OCTOBER 17, 2024

The ABCs of Optimizing Drug Sequencing for IBD

The number of inflammatory bowel disease treatment options with different mechanisms of action has exploded over ...

OCTOBER 13, 2024